Legate
A first contract proves a technology can be bought. Scale proves it can be relied upon.

WRITTEN BY

James Langford
CATEGORY
Legate
READ TIME
4 min read
A first contract proves a technology can be bought. Scale proves it can be relied upon.
In The Legate Brief, No. 2 we argued that good defence technology most often stalls in the gap between a successful trial and a contract. Suppose that gap is crossed. The trial goes well, the requirement is confirmed and a first order is placed. For many young defence companies this feels like arrival. In practice it is the moment the hardest work begins.
A first contract is a vote of confidence. It is not yet a capability. Armed forces do not fight with prototypes or pilot batches. They need equipment in numbers, delivered on schedule, built to a consistent standard and supported for years by spares, training, repair and upgrades. The distance between 100 units and 10,000 is not a matter of doing the same thing more often. It is a different discipline altogether.
Engineering achievement versus industrial achievement
Building 100 units is an engineering achievement. A small, highly skilled team can solve problems as they arise, adjust components by hand and absorb a degree of variation. Building 10,000 is an industrial achievement. Quality has to be designed into tooling, processes and test regimes rather than supplied by individual skill. Documentation, configuration control and certification have to keep pace with every design change. The organisation has to recruit and train people who did not build the prototype and may never meet those who did.
Each of these demands capital before revenue. Tooling, test equipment, factory space and qualified staff must be in place months or years before production units are paid for. For a company whose balance sheet was built for development, this is often the point of greatest financial strain.
Where scale breaks
Three pressure points recur.
The first is the supply chain. A prototype can be built from components bought in small quantities from whoever has stock. At volume, every single source supplier, every long lead item and every export controlled part becomes a potential point of failure. Energetics, microelectronics, specialist metals and optics are well known constraints. Less visible ones, such as a particular connector or a qualified machining subcontractor, can halt a line just as effectively.
The second is the production system itself: the move from workshop to line, with the process engineering, quality assurance and security accreditation that defence customers rightly require.
The third is demand. Manufacturers invest in capacity when they can see sustained orders. A single contract, however welcome, rarely justifies a new line. Without a credible multi year demand signal, the rational decision for industry is to wait, and the rational decision for the buyer is to order cautiously. Each waits for the other.
Policy is moving, but industry still has to deliver
European governments recognise the problem. In October 2026 the European Commission allocated €168.2 million under the European Defence Industry Programme to eight projects at 17 sites across 14 Member States and Norway. The Commission expects these projects to leverage €1.26 billion of industrial investment and, from 2027, to cut manufacturing times for energetic components of missiles, drones and ammunition by up to 90 per cent.
This is welcome, and it addresses one of the most acute bottlenecks. It also illustrates the scale of the task. An Atlantic Council assessment of the EU’s Defence Readiness Roadmap 2030, a year after its publication, found that only around a fifth of the objectives due in 2026 had been completed. Money and plans are necessary. They do not by themselves produce a factory, a trained workforce or a resilient supply chain.
Planning for scale before the first contract
The practical lesson is that scale has to be designed in from the start, not bolted on after success. For innovators, that means asking questions early that can feel premature. Can this be manufactured by people other than its inventors? Which components have only one source? What would it take to produce ten times the current volume, and where? Is the intellectual property clear enough to license or transfer production if needed?
For buyers, it means recognising that the shape of a contract shapes the industrial base. Multi year commitments, framework agreements and clear forecasts give industry the confidence to invest. Short, uncertain orders encourage it to stay small.
For the wider ecosystem, it means connecting validated technology with production capacity and patient finance at the point of transition, rather than leaving each company to solve the problem alone. That is the gap Legate was established to help close.
Deterrence depends on capability that exists in sufficient quantity, not on prototypes that impressed at a trial. Industrialisation is where innovation becomes credible.
In the next Brief we turn to readiness, and to what “battle ready” actually means.
To get in touch, or to apply to the Legate process, visit legatetechnologies.com.

